Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
South Korea
· Delayed Price · Currency is KRW 6,340.00
-10.00 (-0.16%)
At close: Apr 28, 2026
Sinil Pharmaceutical Revenue
In the year 2025, Sinil Pharmaceutical had annual revenue of 80.56B KRW, down -9.92%. Sinil Pharmaceutical had revenue of 21.14B in the quarter ending December 31, 2025, a decrease of -1.90%.
Revenue
80.56B
Revenue Growth
-9.92%
P/S Ratio
0.90
Revenue / Employee
280.71M
Employees
287
Market Cap
72.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 80.56B | -8.88B | -9.92% |
| Dec 31, 2024 | 89.44B | 305.25M | 0.34% |
| Dec 31, 2023 | 89.14B | 9.13B | 11.41% |
| Dec 31, 2022 | 80.01B | 18.25B | 29.56% |
| Dec 31, 2021 | 61.75B | 316.13M | 0.51% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Optipharm.CO.,LTD | 22.34B |
| BL Pharmtech | 6.51B |
| Hwail Pharmaceutical | 107.87B |
| GL Pharm Tech | 35.27B |
| Jin Yang Pharmaceutical | 120.69B |
| Kyung Nam Pharm | 56.18B |
| Sinsin Pharmaceutical | 113.78B |
| Samik Pharmaceutical Company LTD. | 60.02B |